Finance

Lists
300401:SHE
Zhejiang Garden Biopharmaceutical Co Ltd
CNÂ¥14.28
-2.72%
(-0.40) 1D
Aug 26, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300401...
Open
CNÂ¥14.87
High
CNÂ¥14.96
Low
CNÂ¥13.96
Mkt. cap
7.70B
Avg. vol.
33.51M
Volume
25.81M
Dividend
0.79%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 27, 2026
P/E ratio
30.16
52-wk high
CNÂ¥23.44
52-wk low
CNÂ¥10.68
EPS
CNÂ¥0.47
Shares outstanding
544.82M
No. of employees
1K
Open
CNÂ¥14.87
High
CNÂ¥14.96
Low
CNÂ¥13.96
Mkt. cap
7.70B
Avg. vol.
33.51M
Volume
25.81M
Dividend
0.79%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 27, 2026
P/E ratio
30.16
52-wk high
CNÂ¥23.44
52-wk low
CNÂ¥10.68
EPS
CNÂ¥0.47
Shares outstanding
544.82M
No. of employees
1K
About Zhejiang Garden Biopharmaceutical Co Ltd
CEO-
Employees1.16K
FoundedDec 18, 2000
Headquarters-
SectorPharmaceutical industry
Websitehybiotech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
300.34M
301.70M
276.88M
415.22M
Cost of goods sold
136.43M
137.15M
141.57M
237.36M
Cost of revenue
136.43M
137.15M
141.57M
237.36M
Research and development expenses
14.31M
18.22M
23.34M
22.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55.41M
49.66M
45.59M
45.46M
Operating expense
62.68M
84.79M
68.58M
73.58M
Total operating expenses
199.12M
221.94M
210.15M
310.94M
Operating income
101.22M
79.76M
66.73M
104.29M
Other non operating income
1.64M
-2.14M
-7.93M
-15.01M
EBT including unusual items
83.45M
83.67M
56.91M
92.47M
EBT excluding unusual items
94.32M
69.46M
54.19M
94.72M
Income tax expense
10.94M
12.87M
6.64M
10.82M
Effective tax rate
13.11%
15.38%
11.68%
11.70%
Other operating expenses
-8.31M
17.15M
2.77M
2.57M
Net income
72.51M
70.81M
50.27M
81.65M
Net profit margin
24.14%
23.47%
18.16%
19.66%
Earnings per share
-
-
-
-
Interest and investment income
2.73M
2.73M
2.74M
7.35M
Interest expense
-8.32M
-8.97M
-7.35M
-1.91M
Net interest expenses
-5.60M
-6.24M
-4.61M
5.44M
Depreciation and amortization charges
-
-
-
-
EBITDA
140.10M
124.28M
111.26M
150.73M
Gain or loss from assets sale
159.00
2.24M
-
-52.07K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps